1. Home
  2. TIL vs ACU Comparison

TIL vs ACU Comparison

Compare TIL & ACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • ACU
  • Stock Information
  • Founded
  • TIL 2018
  • ACU 1867
  • Country
  • TIL United States
  • ACU United States
  • Employees
  • TIL N/A
  • ACU N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • ACU Industrial Machinery/Components
  • Sector
  • TIL Health Care
  • ACU Consumer Discretionary
  • Exchange
  • TIL Nasdaq
  • ACU Nasdaq
  • Market Cap
  • TIL 171.7M
  • ACU 146.7M
  • IPO Year
  • TIL 2021
  • ACU N/A
  • Fundamental
  • Price
  • TIL $15.46
  • ACU $41.38
  • Analyst Decision
  • TIL Buy
  • ACU
  • Analyst Count
  • TIL 5
  • ACU 0
  • Target Price
  • TIL $114.00
  • ACU N/A
  • AVG Volume (30 Days)
  • TIL 78.2K
  • ACU 14.7K
  • Earning Date
  • TIL 05-09-2025
  • ACU 04-17-2025
  • Dividend Yield
  • TIL N/A
  • ACU 1.46%
  • EPS Growth
  • TIL N/A
  • ACU N/A
  • EPS
  • TIL N/A
  • ACU 2.48
  • Revenue
  • TIL N/A
  • ACU $195,491,991.00
  • Revenue This Year
  • TIL N/A
  • ACU $4.87
  • Revenue Next Year
  • TIL N/A
  • ACU $3.65
  • P/E Ratio
  • TIL N/A
  • ACU $16.70
  • Revenue Growth
  • TIL N/A
  • ACU 2.56
  • 52 Week Low
  • TIL $9.62
  • ACU $32.85
  • 52 Week High
  • TIL $92.00
  • ACU $50.00
  • Technical
  • Relative Strength Index (RSI)
  • TIL 44.19
  • ACU 58.71
  • Support Level
  • TIL $14.96
  • ACU $37.64
  • Resistance Level
  • TIL $18.71
  • ACU $40.99
  • Average True Range (ATR)
  • TIL 1.80
  • ACU 1.96
  • MACD
  • TIL 0.09
  • ACU 0.15
  • Stochastic Oscillator
  • TIL 46.32
  • ACU 89.40

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

Share on Social Networks: